Labiotech.eu Source d'actualité
Aujourd'hui à 16:57
SR One closes biotech fund at $600M
SR One, a transatlantic life sciences investment firm, has announced the close of its second fund at more than $600 million, exceeding its target of $500 million. Fund II is the second fund since SR...
Aujourd'hui à 12:12
Could new riboswitch make gene therapy safer?
Turning genes on and off as easily and predictably as flicking a switch could be a powerful tool in medicine and biotech. A type of technology called a riboswitch might be the key.The Okinawa...
Aujourd'hui à 08:34
Vaccitech announces positive topline data for chronic hepatitis study
Vaccitech plc has announced positive topline final data from the HBV002 study, a phase 1b/2a clinical trial of VTP-300 in people with chronic hepatitis B (HBV) infection. Vaccitech is a clinical-stage...
Hier à 16:57
LIfT BioSciences hails breakthrough data for treating solid tumors
LIfT BioSciences has announced what it says are exciting preclinical data demonstrating that its immunomodulatory alpha neutrophil product (IMANp) possesses both cytotoxic and immunomodulatory...
Hier à 12:12
5 hearing loss biotech companies you should know about
More than 1.5 billion people – nearly 20% of the world’s population – live with hearing loss globally, with 430 million suffering from disabling hearing loss. In this article, we take a look at five...
|SIREN / SIRET||- DE Labiotech|
Berlin Berlin DE Allemagne